To further determine whether LukS-PV exerted antileukemia effects by downregulating SET8 and H4K20me1, we overexpressed or knocked down SET8 in AML cell lines treated in the cells with 3.0 μM of LukS-PV, and apoptosis was assessed by flow cytometry. This evidence concerns the gene KMT5A and acute myeloid leukemia.